|
May 13
|
Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales
|
|
May 8
|
Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development
|
|
Apr 8
|
Trinity Biotech plc (NASDAQ:TRIB) Q4 2023 Earnings Call Transcript
|
|
Apr 5
|
Trinity Biotech PLC (TRIB) Q4 2023 Earnings Call Transcript Highlights: A Glimpse into ...
|
|
Apr 4
|
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
|
|
Mar 28
|
Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results
|
|
Mar 8
|
Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
|
|
Mar 6
|
Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now
|
|
Feb 8
|
Trinity Biotech to Present at Emerging Growth Conference
|
|
Feb 7
|
Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code
|
|
Dec 18
|
Trinity Biotech Announces Management Changes
|
|
Dec 18
|
Trinity Biotech plc (NASDAQ:TRIB) Held Back By Insufficient Growth Even After Shares Climb 31%
|
|
Nov 28
|
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares
|
|
Aug 7
|
Trinity Biotech Announces That It Has Received 510(k) Clearance From The U.S. Food and Drug Administration for the Premier Resolution System
|
|
Apr 27
|
Trinity Biotech Announces the Successful Closing of the $30 Million Sale of its Life Sciences Supply Business to Biosynth
|
|
Apr 24
|
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement
|
|
Apr 23
|
This Trinity Biotech plc (NASDAQ:TRIB) Analyst Is Way More Bearish Than They Used To Be
|